http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RS-53018-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
filingDate 2010-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f427b034de8ed407707c66a10a1e85c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f2c8c1636ead964c1093958651a6770
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b87683420e9b08912e71f91095758a28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f3c0086d706ce49224f58ba705704fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e07139458faf42055582b9f5d45dc05f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4a8743344b88fa6484de4d7153c5932
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03cde0c30811b7dc7bee7f7a84b75abf
publicationDate 2014-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RS-53018-B
titleOfInvention SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS
abstract A compound of the formula: wherein R 1 is fluorine or chlorine, Each of R 2a and R 2b is hydrogen or each is fluorine, R 3 is hydrogen, methyl, hydroxymethyl, or (C 1 -C 3) alkoxymethyl, R 4 is selected from the group consisting of fluorine, chlorine, cyano, cyanomethyl, (C1-C3) alkyl, cyclopropyl, hydroxymethyl, methoxy, cyclopropylmethoxy, aminocarbonylmethoxy, (C1-C3) alkoxymethyl, cyclopropyloxymethyl, cyclopropylmethoxymethyl, 1-hydroxy-1-methylethynymocarbonylo -NR5R6, hydroxyimine, methoxyimine, morpholin-4-yl, morpholin-4-ylmethyl, Ar1, -CH2Ar1, tetrahydrofuran-2-yl, 3-oxomorpholin-4-ylmethyl, 2-oxopyrrolidin-1-ylmethyl, and 2-oxopiperidine R5 is hydrogen, C1-C3 alkyl, cyanomethyl, -C (O) CH3, or aminocarbonylmethyl, R6 is hydrogen or methyl; Ar 1 is a residue selected from the group consisting of imidizol-1-yl, imidizol-2-yl, 2-methylimidizol-1-yl, pyrazol-1-yl, 1,2,3-triazol-1-yl; 1,2,3-triazol-2-yl; 1,2,4-triazol-1-yl, isoxazol-3-yl, oxazol-5-yl, and 3 = methyl-1,2,4-oxadiazol-5-yl; or a pharmaceutically acceptable salt thereof. The application contains 14 more claims.
priorityDate 2009-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457472442
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100135588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29256
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP79292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457832278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457832439
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426344311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415854349
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457640656
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18389
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4987
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP47748
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23529194
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID402851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12665
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456455163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395077
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313

Total number of triples: 58.